- US11793843utility2023Prostate Neoantigens and Their Uses0 cites
- US11787875utility2023Materials and Methods for Improved Single Chain Variable Fragments0 cites
- US11780911utility2023Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha0 cites
- US11760801utility2023Anti-ceacam Antibodies and Uses Thereof0 cites
- US11753393utility2023Dihydroorotate Dehydrogenase Inhibitors0 cites
- US11746161utility2023Antibodies That Specifically Bind PD-1 and Methods of Use0 cites
- US11746157utility2023PSMA Binding Agents and Uses Thereof0 cites
- US11732050utility2023Neutralizing Human Anti-cd27 Antibodies0 cites
- US11732051utility2023Subcutaneous Formulations of Anti-cd38 Antibodies and Their Uses0 cites
- US11713355utility2023Anti-cd38 Antibodies for Treatment of Acute Lymphoblastic Leukemia0 cites
- US11708419utility2023Subcutaneous Formulations of Anti-cd38 Antibodies and Their Uses0 cites
- US11708420utility2023Subcutaneous Formulations of Anti-cd38 Antibodies and Their Uses0 cites
- US11708562utility2023Differentiation of Human Embryonic Stem Cells0 cites
- US11702475utility2023Cysteine Engineered Fibronectin Type III Domain Binding Molecules0 cites
- US11667712utility2023Materials and Methods for Modulating T Cell Mediated Immunity0 cites
- US11639396utility2023Antibody Binding to a Linker Peptide0 cites
- US11633546utility2023Palm Activated Drug Delivery Device0 cites
- US11634499utility2023Control of Trace Metals During Production of Anti-cd38 Antibodies0 cites
- US11618787utility2023Methods of Treating High Risk Multiple Myeloma0 cites
- US11603405utility2023Anti-cd3 Antibodies and Uses Thereof0 cites